Hermes

Exclusive Content

How Record 10 Brand-Name Drugs Winning China Bulk-Buying Bids Affects Foreign Pharma: 2026 Update

A record 10 brand-name drugs won bids in China's 10th round of centralized drug procurement on August 5, 2026, as NHSA introduced a dual-pathway selection mechanism. Here's the new market-access math for multinational pharmaceutical companies.

What Unitree’s ¥55bn IPO Bid Means for Foreign Investors in China Robotics: 2026 Update

Unitree Robotics opened IPO bids implying a ¥55 billion valuation on August 6, 2026, testing whether public markets will support China's humanoid-robot sector. Here's what foreign investors need to know about market access, supply chain dynamics, and competitive positioning.

What China’s Autonomous Driving Safety Mandate Means for Foreign Auto Tech Firms: 2026 Update

China's MIIT issued a new autonomous driving safety mandate requiring 10,000 km real-world validation before commercial deployment, affecting 47 companies across 21 cities. Here are 3 compliance shifts foreign auto tech firms must address before the December 2026 deadline.

China’s SAF Buildout: 16 New Projects vs 4 Globally — Feedstock Squeeze Ahead

China announced 16 new sustainable aviation fuel projects in H1 2026 versus 4 in the rest of the world. State-owned Sinopec and CNPC lead the buildout, tightening global used cooking oil feedstock supply.

GM and SAIC Renew China JV Through 2047: 4 Lessons for Foreign JV Partners

GM and SAIC extended their China joint venture 20 years early, through 2047, ending Chevrolet sales in favor of Buick, Cadillac, localized EV development, and exports. A practical playbook for foreign JV partners.

China’s Tax Net Widens to Offshore Insurance: 20% Levy Hits Hong Kong Policy Returns

Chinese tax authorities are levying 20% personal income tax on returns from Hong Kong insurance policies, enforced through CRS data exchange. What this means for executive benefits and expat packages.